Le Lézard
Classified in: Health
Subjects: TDS, PET

RENOV?® EQUINE ALLOGRAFT WILL SHOWCASE DURING THE 2023 AAEP ANNUAL CONVENTION


ARGYLE, Texas, Nov. 15, 2023 /PRNewswire/ -- Equine Amnio Solutions, LLC (EAS), distributor of the RenoV?® advanced equine allograft, announced today that the product will feature prominently during the 69th Annual Convention of the American Association of Equine Practitioners (AAEP), San Diego, CA held November 29 to December 3, 2023. EAS is a show exhibitor and will be located in Booth 18078.

RENOV?® EQUINE ALLOGRAFT WILL SHOWCASE DURING THE 2023 AAEP ANNUAL CONVENTION

Danica Wolkowski, DVM of Momentum Equine Veterinary Specialists, Sherwood Park, Alberta, Canada, will present compelling RenoV?® clinical data on Friday, December 1 at 8:40 am in a presentation titled, "Effects of Intra-Articular Injection of an Acellular Equine Liquid Amniotic Allograft in Healthy Equine Joints."

RenoV?® will also be a featured product during the Clinical Skills Lab sessions titled, "What's My Aim? Mastering Image-Guided Injection Techniques" on Wednesday, November 29. This session explores ultrasound-guided injections for tendon and ligament lesions and the different products available.

RenoV?® affiliated key-opinion-leaders will present as part of the Product Demo Theater during the trade show. Drs. Rocky Bigbie, DVM and Marty Allen, DVM, BA, MS of Equine Sports Performance, Ocala, FL will speak on the history of therapeutic amnion use in a presentation titled, "Amnion: A fascinating history and a modern equine version" on Thursday, November 30 from 12-12:30 pm. Dr. Dora Ferris, DVM, MS of Summit Equine, Gervais, OR will discuss and present clinical data on the use of RenoV?® in equine practice on Friday, December 1 from 12-12:30 p.m.

RenoV?® is an acellular, cryopreserved liquid allograft derived from equine amniotic tissues collected during live births without harm to the mare or foal. Studies establish the product as a safe and highly effective alternative to other modalities in the clinical care of equine tissue injuries. RenoV?® is manufactured by Equus Innovations (Phoenix, Arizona) and has been used in over 17,000 horses to date.

About Equine Amnio Solutions

Equine Amnio Solutions, LLC (EAS) is the market leader in the distribution of next-generation regenerative veterinary products, including RenoV?®. EAS works closely with its product manufacturer, Equus Innovations (Phoenix, Arizona). Our mission is to provide innovative products to maximize the health and performance of horses across all breeds and athletic disciplines. For more information, visit https://renovoequine.com/.

RenoV?® is a Registered Trademark of Equine Amnio Solutions, LLC.

Equine Amnio Solutions, LLC
308 E FM 1830, Bldg 2, Suite A
Argyle, TX 76226
Phone: (501) 708-5000
www.renovoequine.com

SOURCE Equine Amnio Solutions, LLC


These press releases may also interest you

at 18:05
Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 14:06
Red Door Community Raises more than $300,000 at Their Annual Luncheon Celebrating Women Working and Living with Cancer
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Easy Eats Pandemanila brand Kalihim (Philippine Bread Rolls) recalled due to undeclared egg
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
Industrial Automation Market In Life Sciences Industry size is set to grow by USD 5.06 bn from 2024-2028, growing global demand for healthcare services to boost the market growth, Technavio
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
MODULAR ATP Study of the mCRMtm System Meets Primary Safety and Efficacy Endpoints
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

More news about Health...


News published on and distributed by: